Publications 1991

1991-1) BEHROUZ N., DEFOSSEZ A., DELACOURTE A., MAZZUCA M. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease. J. Gerontol.; 1991, 46 Biol. Sci.: 209-212.

1991-2) BUEE L., BOYLE N., ZHANG L., DELACOURTE A., FILLIT H. Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycans and proteoglycans. Anal. Biochem.; 1991, 195: 238-242.

1991-3) CAILLET-BOUDIN M.L., LEMAY P., BOULANGER P. Functional and structural affects of an Ala to Val mutation in the adenovirus serotype 2 fibre. J. Mol. Biol.; 1991, 217: 477-486.

1991-4) CEBALLOS-PICOT I., NICOLE A., BRIAND P., GRIMBER G., DELACOURTE A., DEFOSSEZ A., JAVOY-AGID F., LAFON M., BLOIN J.L., SINET P.M. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res.; 1991, 552: 198-214.

1991-5) CEBALLOS I., JAVOY-AGID F., DELACOURTE A., DEFOSSEZ A., LAFON M., HIRSCH E. Neuronal localization of copper-zinc superoxide dismutase protein and messenger RNA within the human hippocampus from control and Alzheimer's disease brains. Free Radical Research Communications; 1991, 12: 571-580.

1991-6) CEBALLOS I., NICOLE A., BRIAND P., GRIMBER G., DELACOURTE A., FLAMENT S. Expression of Human Cu-Zn superoxide dismutase gene in transgenic mice. Model for gene dosage effect in Down Syndrome. Free Radical Research Communications; 1991, 12: 581-589.

1991-7) FILLIT H., DING W., BUEE L., KALMAN J., ALTSTIEL L., LAWLOR B., WOLF-KLEIN G. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett.; 1991, 129: 318-320.

1991-8) FLAMENT S., DELACOURTE A., VERNY M., HAUW J.J., JAVOY-AGID F. Abnormal Tau proteins in Progressive Supranuclear Palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol.; 1991, 81: 591-596.

1991-9) FURBY A., LEYS D., DELACOURTE A., BUEE L., SOETAERT G., PETIT H. Are Alpha-1-antichymotrypsin and Inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?. J. Neurol. Neurosurg. and Psy.; 1991, 54: 469.

1991-10) LEYS D., PRUVO J.P., PARENT M., VERMERSCH P., SOETART G., STEINLING M., DELACOURTE A., DEFOSSEZ A., RAPOPORT A., CLARISSE J., PETIT H. Could Wallerian degeneration be a factor of "leuko-araiosis" in subjects free of any vascular disorder ? J. Neurol. Neurosurg. and Psy.; 1991, 54: 46-50.